Novel NIR probes for multiplexed imaging of cancer
Active Grant Awarded Last action
- Award ID
- R15EB038727
- Recipient
-
University Of Nebraska UEI FZRNFQTKADH1
- Awarding agency
-
National Institute of Biomedical Imaging and Bioenginering
National Institutes of Health, Department of Health and Human Services
- Obligated
- $572,947
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 12% complete
- Place of performance
- Omaha, NE 68182, USA
Award details come from USAspending.gov.
About this award
The National Institute of Biomedical Imaging and Bioengineering, within the National Institutes of Health and the Department of Health and Human Services, awarded Grant R15EB038727 to the University of Nebraska at Omaha on July 17, 2026, obligating $572,947 under the Biomedical Research and Research Training program (CFDA 93.859). The award funds an Academic Research Enhancement Award (AREA) R15 project to develop near-infrared (NIR) probes for early detection of ovarian cancer and image-guided cytoreductive surgery. The work centers on a user-friendly, modular toolkit of highly emissive, stable NIR probes built on DNA-templated silver nanoclusters (DNA-AGNCs), optimized for ovarian cancer imaging. The period of performance runs to June 30, 2029, and performance takes place in Omaha, Nebraska (ZIP 68182).
The University of North Carolina at Charlotte holds a sub-award under this grant, designated R15EB038727-44-0516-1000-202 and dated September 25, 2026, for work described as novel NIR probes for imaging of cancer.
Description
- Abstract
- Ovarian cancer, particularly aggressive epithelial tumors, remains a major health threat with ~46% overall survival rates. Early detection greatly improves the five-year survival to 94%. In advanced stages, cytoreductive procedures become critical and require precise tumor visualization for diagnosis and surgical guidance. Conventional imaging methods like CT, MRI, and ultrasound lack real-time precision, especially in detecting small peritoneal nodules, forcing surgeons to rely on visual inspection and palpation without real-time guidance. Bioimaging plays a critical role in diagnosing ovarian cancer, guiding cytoreductive surgical interventions, and evaluating treatment efficacy. While minimally invasive fluorescence bioimaging holds great potential, its clinical adoption is limited by a shortage of effective imaging agents. Thus, there is an urgent need for improved diagnostic tools and enhanced surgical techniques. This academic research enhancement award (AREA) R15 proposal aims to develop near-infrared (NIR) probes for early detection of ovarian cancer and image-guided cytoreductive surgery. Specifically, we will create a user-friendly, modular toolkit for highly emissive and stable NIR probes based on DNA-templated silver nanoclusters (DNA-AGNCS) optimized for ovarian cancer imaging. DNA-AGNCS offer superior stability, high quantum yields, and low toxicity compared to conventional organic and inorganic probes. Our preliminary results indicate that stable NIR-emitting DNA-AGNCS can be reproducibly engineered using specific DNA sequences, with emission wavelengths tunable via ligand interactions and redox state modulation. Also, our interdisciplinary research team has demonstrated that programmable nucleic acid nanoparticles (NANPS) can stabilize AGNCS and, when decorated with targeting moieties, can specifically bind cancer cells. TBY elucidating the design principles of DNA-AGNCS, this research will unlock the full potential of NIR optical imaging, advancing both image-guided surgery and early ovarian cancer detection. Furthermore, this AREA award will expand undergraduate research opportunities, providing hands-on training and enhancing student preparedness for careers in the biomedical field.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $222,947 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of North Carolina At Charlotte | $221,760 |
Quick answers
Who received award R15EB038727?
R15EB038727 was awarded to University Of Nebraska by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on July 17, 2026.
How much is award R15EB038727 worth?
$572,947 has been obligated on R15EB038727.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award